Compound Detail
CHEMBL121626
TOLFENAMIC ACID 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL121626 |
| Name | TOLFENAMIC ACID |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | YEZNLOUZAIOMLT-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
10
Targets
13
Activities
4
Assay Types
10
PK Parameters
20
Publications
7
Known Names
3
Indications
Molecular Properties
261.7
MW (Da)
4.09
ALogP
2
HBA
2
HBD
49.3
PSA (Ų)
0.87
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Rheumatic Diseases Pancreatic Neoplasms Supranuclear Palsy, Progressive
ATC Classification
M01AG02
tolfenamic acid
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
Activity Summary
IC50 9 meas. best 6.34
Ki 2 meas. best 8.1
EC50 1 meas. best 4.82
Kd 1 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aldo-keto reductase family 1 member C3 CHEMBL4681 | Ki | 8.1 | 8.1 | 8.0 | 1 |
| Transthyretin CHEMBL3194 | Kd | 6.82 | 6.82 | 150.0 | 1 |
| Staphylococcus aureus CHEMBL352 | IC50 | 6.34 | 6.34 | 459.0 | 1 |
| Prostaglandin G/H synthase 2 CHEMBL230 | IC50 | 6.06 | 6.06 | 880.0 | 1 |
| Cytochrome c oxidase subunit 2 CHEMBL6174 | IC50 | 5.93 | 5.89 | 1170.0 | 2 |
| Phospholipase A2 CHEMBL4426 | IC50 | 5.11 | 5.11 | 7740.0 | 1 |
| Cysteine protease ATG4B CHEMBL1741221 | IC50 | 5.09 | 5.09 | 8170.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 4.82 | 4.82 | 15000.0 | 1 |
| Transthyretin CHEMBL3194 | IC50 | 4.4 | 4.4 | 40000.0 | 1 |
| Androgen receptor CHEMBL1871 | IC50 | 4.33 | 4.33 | 47000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.16 | 4.16 | 70000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | - | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 155.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 176.0 | mL.min-1.g-1 | Homo sapiens |
| CL | - | - | Homo sapiens |
| Fu | 0.88 | - | Homo sapiens |
| Fu | - | - | Homo sapiens |
| T1/2 | 100.0 | hr | Homo sapiens |
| T1/2 | 0.08333 | hr | Homo sapiens |
| Tmax | 2.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine